肝康合剂联合干扰素治疗慢性乙型肝炎54例
中西医结合医学;肝康合剂;干扰素;肝炎,临床对照研究,,],中西医结合医学;肝康合剂;干扰素;肝炎,临床对照研究,1资料与方法,2结果,3讨论,[参考文
[摘要] 目的 研究肝康合剂联合干扰素治疗慢性乙型肝炎的临床疗效。方法 选择慢性乙型肝炎的病例,应用肝康合剂联合干扰素进行治疗,以单独应用肝康合剂和单独应用干扰素治疗的患者进行对比观察,疗程均为6个月。观察患者治疗前后症状、体征的改善情况,肝功能、乙肝病毒标志物的变化情况。结果 治疗结束后治疗组与两对照组总有效率分别为94.4%和90.4%、85.0%,无统计学差异,P>0.05;在肝功能复常方面,3组亦无统计学差异,P>0.05;在HBeAg、HBV-DNA阴转方面,治疗组明显优于对照组,统计学处理差异有显著性(P<0.01或0.05)。结论 肝康合剂联合干扰素治疗慢性乙型肝炎具有较好疗效,肝康合剂能明显提高干扰素的抗乙肝病毒效果。[关键词] 中西医结合医学;肝康合剂;干扰素;肝炎,临床对照研究
Gankang mixture combined inferon in treatment of chronic hepatitis B:a report of 54 cases
JIN Tao,YOU Yun-ge,LI Qing-xiu,et al.Linli Hospital of Traditional Chinese Medicine,Changde 415200,China
[Abstract] Objective To study the clinical curative effect of combined treatment with Gankang mixture and interferon in treating chronic hepatitis B.Methods Therapeutic group treated with Gankang mixture and interferon contrast group 1 and 2 treated only by Gankang mixture and interferon respectively;all to treat 6 months;the symptoms and signs of the three groups were observed before and after the treatment ......
您现在查看是摘要页,全文长 8096 字符。